Colony Group’s Alkermes ALKS Stock Holding History

Colony Group’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-450	Closed	-$36K	–	257
2015 Q4	$36K	Buy	+450	New	+$31.5K	﹤0.01%	517

Other funds holding ALKS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Colony Group's ALKS Position: Q1 2016 in Review

Colony Group sold out of Alkermes (ALKS) in Q1 2016, closing a stake of 450 shares — an estimated $36K sold.

Colony Group first reported a position in ALKS in Q4 2015 and held it in 1 quarter. The position peaked at $36K in Q4 2015. 242 funds tracked by Wall St. Rank hold ALKS as of Q1 2016.

Colony Group reported no remaining Alkermes position as of Q1 2016 after selling out during the quarter.
Colony Group sold 450 Alkermes shares in Q1 2016, an estimated $36K.
Colony Group first reported a position in Alkermes in Q4 2015 and held it in 1 quarter.
Colony Group's Alkermes position peaked at $36K in Q4 2015.
242 funds tracked by Wall St. Rank held Alkermes as of Q1 2016.

Based on Colony Group's 13F filing for Q1 2016, filed 16 May 2016.